Bixiye
QP11-22 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective April 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Natiijooyinka Raadinta
Soo bandhiga 1561 - 1570 ee natiijooyinka 4296
Bixiye
QP12-22 MHCP Pharmacy Benefit Exclusion for Apretude, Tezspire™ and Vyvgart™
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Bixiye
QP13-22 Commercial Pharmacy Benefit Exclusion for Apretude, Tezspire™ and Vyvgart™
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Bixiye
P5-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P6-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P7-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P8-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Sleep Management Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P9-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective April 4, 2022
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022